Press

Alora Pharmaceuticals Celebrates Acquisition of Monarch Manufacturing Facility

January 10, 2023

Alora Pharmaceuticals, LLC, is pleased to announce that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in...

Learn More

Avion Pharmaceuticals proudly supports World Menopause Awareness Month

October 3, 2022

The World Health Organization (WHO) and the International Menopause Society designates October as World Menopause Month. In recognition of October as World Menopause Awareness Month, Avion Pharmaceuticals encourages our women’s...

Learn More

Alora Pharmaceuticals Wins Top Pharmaceutical Award – Best of the Best in Healthcare Marketing Honored at Event in NYC on September 23rd

September 30, 2022

PM360, a leading life sciences marketing industry trade publication, announced the winners of their 14th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022....

Learn More

Shannon Faught Named 2022 Women of Influence by the Atlanta Business Chronicle

September 14, 2022

Alora Pharmaceuticals, LLC a specialty pharmaceutical company based in Alpharetta, GA is pleased to announce that Shannon Faught, Chief Commercial Officer for Alora’s branded pharmaceutical business has been recognized as...

Learn More

Alora Pharmaceutical’s DHIVY Marketing Team recognized by PM 360 Magazine as a finalist for Marketing Team of the Year

August 25, 2022

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering...

Learn More

Alora Pharmaceuticals adds Chief Quality Officer to its Senior Leadership Team

July 7, 2022

Pharmaceutical Executive Miguel Gomez will lead Alora Pharmaceutical Global Quality strategies Alora Pharmaceuticals, announced today that Miguel Gomez, has been appointed Chief Quality Officer. With his appointment, Alora Pharmaceuticals, LLC...

Learn More
EY Entrepreneur of the Year logo

EY Announces Art Deas, of Alora Pharmaceuticals as an Entrepreneur Of The Year® 2022 Southeast Award Finalist

June 23, 2022

Celebrating ambitious pioneers tackling our biggest challenges Ernst & Young LLP (EY US) has announced that Harold “Art” Deas, of Alora Pharmaceuticals was named an Entrepreneur Of The Year® 2022...

Learn More

Alora Pharmaceuticals Strengthens Leadership Team with Experienced Chief Commercial Officer

June 20, 2022

Pharmaceutical Executive Shannon Faught will lead Alora Pharmaceutical commercial strategies Alora Pharmaceuticals, announced today that Shannon Faught has been appointed Chief Commercial Officer. In this role, Ms. Faught will lead...

Learn More

Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY™ for the treatment of Parkinson’s disease

February 14, 2022

Parkinson's Disease Treatment is the First and Only Carbidopa/Levodopa (CD/LD) TabletDesigned to be Divided for Precise Dosing Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announced the commercial launch of DHIVY,...

Learn More

Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC Top MedReps Best Places to Work in Medical Sales

December 2, 2021

Alora Pharmaceuticals’ Subsidiaries Awarded Top Small Employer for Fourth Consecutive Year Alora Pharmaceuticals today announced its subsidiaries Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC earned the top spot for small...

Learn More

Healthcare & Pharmaceutical Awards 2020 – AVION is “The Most Innovative Women’s Health Pharmaceutical Company in USA”

January 5, 2021

Starting 2021 on some very exciting news!! Avion has been awarded “The Most Innovative Women’s health Pharmaceutical Company in USA” by Global Health & Pharma (GHP) and the official press...

Learn More

Avion Pharmaceuticals, LLC, and Acella Pharmaceuticals, LLC, awarded 2nd consecutive ‘Best Place to Work in Medical Sales*’ recognition

December 3, 2020

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, and affiliate company Acella Pharmaceuticals, LLC, have earned back-to-back annual recognition as the "Best Place to Work in Medical Sales: Small Pharma Category."...

Learn More

Avion Pharmaceuticals, LLC, to Expand Its Women’s Healthcare Portfolio of Products

November 12, 2020

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, has announced a license and commercialization agreement with Aspen Pharma USA Inc. and Aspen Global Incorporated, both wholly owned subsidiaries of Aspen Pharmacare...

Learn More

Important Information About COVID-19

March 17, 2020

As a valued member of the Avion Pharmaceuticals’ community, nothing is more important to us than your health and safety. As the spread of coronavirus, known as COVID-19, continues to...

Learn More

Avion Pharmaceuticals, LLC, named a “Best Place to Work in Medical Sales” by MedReps

January 6, 2020

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announces it received the 2020 “Best Place to Work in Medical Sales: Small Pharma Category” award from MedReps, the leading job site for...

Learn More

Miesha Tate, Former UFC Champion, Partners with Avion Pharmaceuticals, LLC

February 13, 2019

Avion Pharmaceuticals, LLC., a women’s health pharmaceutical company, is partnering with Miesha Tate, a former UFC and MMA champion, to bring greater awareness to the importance of prenatal care and...

Learn More

Alora Pharmaceuticals, LLC, Announces Corporate Office Expansion

March 1, 2018

Alora Pharmaceuticals, LLC, parent company of Avion Pharmaceuticals, LLC, and Acella Pharmaceuticals, LLC, announced the relocation of the corporate headquarters of its two companies to a new 58,000 sq. ft....

Learn More

Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category

January 19, 2018

Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra™ (levonorgestrel and ethinyl estradiol...

Learn More

Prenate® Vitamin Family Boosts Tolerance and Compliance with Prenatal Vitamin Formulas, Uniquely Designed to Address Specific Needs and Stages of Pregnancy, from Preconception through Postpartum

June 8, 2017

Avion Pharmaceuticals, a specialty pharmaceutical company providing innovative pharmaceutical and dietary supplement products, focused on women’s health and dermatology, recognizes the important role prenatal vitamins play in a healthy pregnancy....

Learn More

Avion Pharmaceuticals, LLC, relaunches Prenate® website featuring interactive tool to assist women in making healthful pregnancy choices

October 21, 2016

In its continuing effort to illustrate the enhanced benefits of Avion’s Prenate® line of prenatal dietary supplements, Avion pharmaceuticals, LLC, recently relaunched its product-based website, www.prenate.com. The relaunch was designed...

Learn More

Avion Pharmaceuticals, LLC renews ongoing partnership with Gnosis, S.P.A., to license Quatrefolic®, body-ready folate, through patent life of 2028

August 17, 2016

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company and maker of Prenate® prescription prenatal vitamins, recently announced it has solidified its continuing partnership with Gnosis S.P.A. to provide Quatrefolic®, the fourth-generation...

Learn More

Avion Pharmaceuticals, LLC and Prenate® Restore, prescription post-partum supplement with probiotics, supports National Breastfeeding Month

August 5, 2016

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to support the United States Breastfeeding Committee’s (USBC) designation of August as National Breastfeeding Month. Avion applauds the efforts of the...

Learn More

Avion Pharmaceuticals to exhibit at the American College of Obstetricians and Gynecologists 2016 Annual Clinical and Scientific Meeting

May 10, 2016

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced it will be exhibiting at the American College of Obstetricians and Gynecologists (ACOG), Women’s Healthcare Physician’s 2016 Annual Clinical and Scientific...

Learn More

Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer

April 5, 2016

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to announce the appointment of Harold A. Deas, Jr. as Chief Executive Officer. Mr. Deas, who will retain his role as...

Learn More

Avion Pharmaceuticals, LLC., proudly supports National Birth Defects Prevention Month

January 5, 2016

The National Birth Defects Prevention Network (NBDPN) and the U.S. Centers for Disease Control and Prevention (CDC) have invited women and their families to make a PACT for birth defects...

Learn More

Avion Pharmaceuticals, LLC, awarded HDMA Diana Manufacturer Award

June 9, 2014

Avion Pharmaceuticals was nominated and awarded a prestigious Healthcare Distribution Management Association (HDMA) 2014 Diana Award for the Best Manufacturer of the Year Award under $300MM. This is a highly...

Learn More

Avion Pharmaceuticals, LLC, announces their strategic alliance with Albion® Laboratories, Inc.

April 21, 2014

Avion Pharmaceuticals, a specialty pharmaceutical company, is pleased to announce their business partnership with Utah based Albion® Laboratories. This collaboration will focus on the licensing of unique, patented API ingredients...

Learn More

Mike Sullivan named President of Avion Pharmaceuticals, LLC.

February 25, 2014

Avion Pharmaceuticals, a specialty pharmaceutical company, announces the promotion of Mike Sullivan to the position of President. Mike joined Avion Pharmaceuticals in 2011 as Vice President of Sales and Marketing....

Learn More

Avion Pharmaceuticals, LLC, announces the launch of Prenate® Enhance and Prenate® Restore

January 21, 2014

Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of two advanced vitamin formulations as the newest additions to the Prenate® Vitamin Family. Prenate® Enhance and Prenate® Restore have...

Learn More

Avion Pharmaceuticals, LLC, announces strategic alliance with Nephro-Tech 1, LLC

January 8, 2014

Avion Pharmaceuticals, a specialty pharmaceutical company, announced its recent transaction with Shawnee, Kan.-based Nephro-Tech 1, LLC, to license and market Formical® (calcium formate) on a semi-exclusive basis as part of...

Learn More

Avion Pharmaceuticals, LLC., announces sponsorship of the NNP in Women’s Health Annual Meeting

October 1, 2013

Avion Pharmaceuticals, a specialty pharmaceutical company, participated as an exhibitor at the annual Nurse Practitioners in Women’s Health Annual Meeting, held September 26-28th at the Hilton Bayfront in San Diego,...

Learn More

Avion Pharmaceuticals, LLC., exhibitor at American College of Nurse Midwives Annual Meeting

June 6, 2013

Avion Pharmaceuticals, a specialty pharmaceutical company, is pleased to announce their recent participation in the American College of Nurse Midwives (ACNM ) Annual Meeting in Nashville, Tennessee from May 29th...

Learn More

Avion Pharmaceuticals, LLC., is pleased to announce Prenate Chewable™

May 13, 2013

Avion Pharmaceuticals, a specialty pharmaceutical company, announces the launch of Prenate® Chewable, a chewable prescription prenatal vitamin with a delicious chocolate flavor. For Avion Pharmaceuticals, the launch of Prenate® Chewable...

Learn More

Avion Pharmaceuticals, LLC., presents Nicomide® at the Annual American Academy of Dermatology (AAD)

March 6, 2013

Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual American Academy of Dermatology Meeting. The meeting was held at the Miami Beach Convention Center...

Learn More

Avion Pharmaceuticals, LLC., announces participation in the 2013 Annual Meeting of the SAAOG

January 25, 2013

Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual meeting of the South Atlantic Association of Obstetrics and Gynecologists (SAAOG). The meeting was held...

Learn More

Avion Pharmaceuticals, LLC., announces participation in the NPWH Health Meeting

October 9, 2012

Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual Nurse Practitioner in Women’s Health Meeting. The meeting is planned for October 10-13th, 2012 at...

Learn More